Loading lessons…
Loading lessons…
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
Choose a learning path below or search the library. Progress saves in your browser.
Prefer timeline chaos? Peptide X Quiz · Literacy certify
Pick a track — progress rings update as you complete lessons.
18 lessons
9mTesamorelin makes more sense when you track the body it changes, not just the number on the scale. Waist, liver fat, IGF-1, and lean mass tell the real story.
9mPemvidutide is interesting because it does not just ask whether body weight falls. It asks whether liver fat, waist size, appetite, and recovery move together in a clean direction.
9mScale weight can lie when appetite drops, water shifts, and training changes. This checklist shows the signals that matter more than a single number on the scale.
9mThe hard part of retatrutide is not the first week. It is what happens when appetite falls faster than planning improves. Protein, training, and sleep start to pay the bill.
8mRetatrutide is still the loudest metabolic signal in the room. The people who get the best result are the ones who track body composition, not just pounds lost.
9mWhen appetite drops, structure matters more. The people who keep the best retatrutide results are the ones who protect protein, training, and hydration before the scale gets noisy.
Tesamorelin is a body-composition tool, not a bathroom-scale trick. The best results show up when you track the right metrics from the start.
9mRetatrutide changes the appetite game fast. The people who get the best result are the ones who keep protein, training, and waist measurements in view at the same time.
Retatrutide is forcing a better conversation about fat loss. The scale matters, but body composition, protein, and strength tell you whether the result will hold.
9mThe GH-IGF1 axis keeps showing up in peptide medicine because it links visceral fat, recovery, and lean mass. The trick is separating the clinical signal from the wellness noise.
9mThe real test for retatrutide is not whether it moves the scale. It is whether it makes the plan easier to follow without flattening training, energy, or lean mass.
8mGLP-1s can drive impressive weight loss, but the real win is losing fat without giving up strength. This guide shows how to protect lean mass while appetite is down.
8mScale weight is noisy. If you are using retatrutide, waist trend, body composition, protein intake, and strength matter more than a single weigh-in.
8mTesamorelin has one of the stronger human-data profiles in the peptide space. A 2026 meta-analysis helps clarify what it improves, what it does not, and how to track the signal honestly.
7mA new 2026 meta-analysis puts real numbers on lean mass change during semaglutide, tirzepatide, and liraglutide weight loss. The practical takeaway is not panic. It is better tracking.
8mNew 2026 reviews show a nutrition gap in GLP-1 and incretin therapy research. Here is how to protect protein intake, lean mass, hydration, and labs while appetite is suppressed.
10mThe biggest risk with GLP-1 weight loss drugs isn't the fat loss — it's the muscle you lose with it. Strategic peptide stacking can tip the balance toward true body recomposition.
10mRapid fat loss typically means muscle loss. But retatrutide's triple action—including glucagon receptor activation—preserves more lean mass than tirzepatide or GLP-1-only compounds. Here's the science.
Also available at /blog for legacy links.